InsiderTrades

Gaslightwala Abizer

SEC CIK 2049375 · EDGAR

Buying vs selling by month open-market trades, last 24 months, AKTX
BoughtSold

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
AKTXAkari Therapeutics PlcPres, CEO, Dir 298.6K $56.7K — 122024-12-262025-08-21

Most active insiders at AKTX, 12 months

#InsiderTitleBoughtSold
1 Farag Kameel D.Interim CFO ——
2 Patel Samir RashmikantDir, 10% ——

Gaslightwala Abizer made no open-market trades at AKTX in the last 12 months.

Transactions 12

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
M 2025-08-29 2025-08-21+ AKTX Akari Therapeutics Plc Gaslightwala Abizer CEO, Dir P - Purchase $0.9305 +21.0K 298.6K +8% +$19.5K
M 2025-06-25 2025-06-23+ AKTX Akari Therapeutics Plc Gaslightwala Abizer Pres, CEO, Dir P - Purchase $1.16 +6,146 272.4K +2% +$7,120
2025-06-24 2025-06-20 AKTX Akari Therapeutics Plc Gaslightwala Abizer Pres, CEO, Dir P - Purchase $1.20 +10.0K 271.4K +4% +$12.0K
2025-06-20 2025-06-17 AKTX Akari Therapeutics Plc Gaslightwala Abizer Pres, CEO, Dir P - Purchase $1.20 +15.0K 261.4K +6% +$18.0K
M 2025-06-16 2025-06-12+ AKTX Akari Therapeutics Plc Gaslightwala Abizer CEO, Dir A - Grant $1.21 +45.0K 246.4K +22% +$54.4K
2025-06-12 2025-06-10 AKTX Akari Therapeutics Plc Gaslightwala Abizer CEO, Dir A - Grant $1.27 +20.0K 201.4K +11% +$25.4K
D 2025-03-10 2025-03-06 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $1.12 +133.9K 181.4K +282% +$150.0K
A 2025-02-07 2025-01-10 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $1.22 +11.6K 47.5K +32% +$14.2K
2025-01-13 2025-01-10 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $1.22 +11.4K 35.9K +47% +$14.0K
2025-01-07 2025-01-03 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $0.00 +1.72M 71.72M +2% $0
2024-12-30 2024-12-27 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $0.00 +40.00M 70.00M +133% $0
2024-12-27 2024-12-26 AKTX Akari Therapeutics Plc Gaslightwala Abizer Dir A - Grant $0.00 +30.00M 30.00M New $0

Purchase Sale Sale after option exercise All abbreviations